COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,677 | +15.0% | 970 | +10.6% | 0.00% | – |
| Q2 2023 | $18,843 | -91.9% | 877 | -91.0% | 0.00% | – |
| Q1 2023 | $233,805 | +64.7% | 9,751 | +59.9% | 0.00% | – |
| Q4 2022 | $142,000 | +52.7% | 6,099 | +4.3% | 0.00% | – |
| Q3 2022 | $93,000 | +564.3% | 5,846 | +620.8% | 0.00% | – |
| Q2 2022 | $14,000 | -12.5% | 811 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | +33.3% | 811 | +17.4% | 0.00% | – |
| Q4 2021 | $12,000 | -40.0% | 691 | -33.5% | 0.00% | – |
| Q3 2021 | $20,000 | -25.9% | 1,039 | -9.6% | 0.00% | – |
| Q2 2021 | $27,000 | +8.0% | 1,149 | +7.2% | 0.00% | – |
| Q1 2021 | $25,000 | -16.7% | 1,072 | -30.4% | 0.00% | – |
| Q4 2020 | $30,000 | +30.4% | 1,541 | +35.3% | 0.00% | – |
| Q3 2020 | $23,000 | -8.0% | 1,139 | -18.4% | 0.00% | – |
| Q2 2020 | $25,000 | +127.3% | 1,395 | +104.5% | 0.00% | – |
| Q1 2020 | $11,000 | – | 682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
| Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
| OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
| Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
| CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
| Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
| OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
| Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |